Efficacy Study of CYT997 in Multiple Myeloma

• Status: Terminated
• Trial end date: 2011-02-01

Summary

This is a clinical research study that is designed to test the safety of CYT997 when given to patients with multiple myeloma and to test if CYT997 has any activity against that cancer.

• Phase: Phase 2

Details

• Lead Sponsor: Gilead Sciences